Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
52.9M
-
Number of holders
-
50
-
Total 13F shares, excl. options
-
35.7M
-
Shares change
-
+414K
-
Total reported value, excl. options
-
$573M
-
Value change
-
+$8.46M
-
Put/Call ratio
-
0
-
Number of buys
-
26
-
Number of sells
-
-15
-
Price
-
$16.07
Significant Holders of Tyra Biosciences, Inc. - Common Stock (TYRA) as of Q1 2023
58 filings reported holding TYRA - Tyra Biosciences, Inc. - Common Stock as of Q1 2023.
Tyra Biosciences, Inc. - Common Stock (TYRA) has 50 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35.7M shares
of 52.9M outstanding shares and own 67.41% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (7.24M shares), Boxer Capital, LLC (6.45M shares), Canaan Partners XI LLC (4.41M shares), BVF INC/IL (3.24M shares), FMR LLC (3.15M shares), Nextech Invest Ltd. (2.52M shares), TCG Crossover Management, LLC (1.99M shares), Frazier Life Sciences Management, L.P. (1.42M shares), Fairmount Funds Management LLC (1.42M shares), and BlackRock Inc. (667K shares).
This table shows the top 50 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.